SpiderRock Advisors’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

SpiderRock Advisors’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,149	Closed	-$8.3K	–	830
2024 Q1	$8.3K	Buy	+1,149	New	+$5.49K	﹤0.01%	728

Other funds holding TCON

GPFA

Game Plan Financial Advisors Westlake, Ohio $222M AUM 22.82% 1-Year Est. Return

SpiderRock Advisors's TCON Position: Q2 2024 in Review

SpiderRock Advisors sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2024, closing a stake of 1,149 shares — an estimated $8.3K sold.

SpiderRock Advisors first reported a position in TCON in Q1 2024 and held it in 1 quarter. The position peaked at $8.3K in Q1 2024. 1 fund tracked by Wall St. Rank holds TCON as of Q2 2024.

SpiderRock Advisors reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
SpiderRock Advisors sold 1,149 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $8.3K.
SpiderRock Advisors first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
SpiderRock Advisors's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $8.3K in Q1 2024.
1 fund tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on SpiderRock Advisors's 13F filing for Q2 2024, filed 12 Aug 2024.